← all signals · sectors · research
Tarsus Pharmaceuticals, Inc. TARS
SIC 2836 — Biological Products, (No Diagnostic Substances) · CIK 1819790
This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).
FY2023 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +2.05% |
| 60 days | -0.78% |
| 252 days (1y) | -14.91% |
FY2022 short
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +1.36% |
| 60 days | -1.61% |
| 252 days (1y) | -16.85% |
FY2021 long
1 signal fired ·
match: singles_avg
| Horizon | Predicted net PnL |
|---|---|
| 20 days | +1.81% |
| 60 days | +4.48% |
| 252 days (1y) | +19.70% |
Methodology: /methodology · Live JSON: /api/company/1819790/financials